The Supreme Court on Wednesday announced that it will consider a case involving the availability of abortion pills, the court’s first major abortion case since overturning Roe vs. Wade last year.
The case deals with whether mifepristone, the most common form of medication abortion, can be prescribed through telemedicine and shipped to women through the mail.
The high court will hear two consolidated cases pitting the Alliance for Hippocratic Medicine, a group of doctors and others who oppose abortion, against the Food and Drug Administration (FDA) and Danco Laboratories, the maker of mifepristone.
A date for oral arguments has not yet been announced, but the court is expected to issue a ruling on the case next summer.
The Biden administration asked the Supreme Court to consider the abortion pill case after a federal appeals court panel issued a ruling curbing access to…
